1. Home
  2. RDI vs MYO Comparison

RDI vs MYO Comparison

Compare RDI & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RDI

Reading International Inc

HOLD

Current Price

$1.29

Market Cap

31.6M

ML Signal

HOLD

Logo Myomo Inc.

MYO

Myomo Inc.

HOLD

Current Price

$0.93

Market Cap

33.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDI
MYO
Founded
1937
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.6M
33.2M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
RDI
MYO
Price
$1.29
$0.93
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
34.5K
801.8K
Earning Date
11-14-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$211,292,000.00
$41,643,203.00
Revenue This Year
$6.85
$24.69
Revenue Next Year
$10.86
$20.91
P/E Ratio
N/A
N/A
Revenue Growth
7.11
65.00
52 Week Low
$1.17
$0.71
52 Week High
$1.87
$7.17

Technical Indicators

Market Signals
Indicator
RDI
MYO
Relative Strength Index (RSI) 47.25 55.98
Support Level $1.23 $0.71
Resistance Level $1.33 $0.95
Average True Range (ATR) 0.07 0.07
MACD 0.01 0.02
Stochastic Oscillator 54.67 84.63

Price Performance

Historical Comparison
RDI
MYO

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

Share on Social Networks: